Analysis of activity uptake, effective half-life and time-integrated activity for low- and high-risk papillary thyroid cancer patients treated with 1.11 GBq and 3.7 GBq of 131I-NaI respectively

2019 ◽  
Vol 65 ◽  
pp. 143-149
Author(s):  
Pablo Mínguez ◽  
Emilia Rodeño ◽  
José Genollá ◽  
Maite Domínguez ◽  
Amaia Expósito ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
High Risk ◽  
Cancer Patients ◽  
Papillary Thyroid Cancer ◽  
Half Life ◽  
Papillary Thyroid

Detection of Residual Lymph Node Metastases in High-Risk Papillary Thyroid Cancer Patients Receiving Adjuvant I-131 Therapy

2010 ◽  
Vol 35 (1) ◽  
pp. 6-11 ◽  
Author(s):  
Koichiro Kaneko ◽  
Koichiro Abe ◽  
Shingo Baba ◽  
Takuro Isoda ◽  
Hidetake Yabuuchi ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Lymph Node ◽  
High Risk ◽  
Cancer Patients ◽  
Papillary Thyroid Cancer ◽  
Lymph Node Metastases ◽  
Papillary Thyroid ◽  
Node Metastases

scholarly journals RNA-sequencing investigation identifies an effective risk score generated by three novel lncRNAs for the survival of papillary thyroid cancer patients

Oncotarget ◽  
2017 ◽  
Vol 8 (43) ◽  
pp. 74139-74158 ◽  
Author(s):  
Yi-Huan Luo ◽  
Liang Liang ◽  
Rong-Quan He ◽  
Dong-Yue Wen ◽  
Guo-Fei Deng ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Cancer Patients ◽  
Rna Sequencing ◽  
Papillary Thyroid Cancer ◽  
Risk Score ◽  
Papillary Thyroid
Sign in / Sign up

Export Citation Format

Share Document